GM, Crossix Analytics | Veeva
In this DHCG Disruptive Dose episode, Mark Bard of the DHC Group sits down with Sarah Caldwell, GM, Crossix Analytics of Veeva, to explore how life sciences companies can better leverage data to connect with healthcare professionals (HCPs) and patients in a fragmented media landscape. Sarah emphasizes the need for more personalized, omnichannel strategies that align with evolving behaviors and expectations across both segments. They also discuss the importance of real-time measurement, privacy-conscious data use, and collaboration across marketing, sales, and compliance teams to ensure impactful engagement. As AI and digital tools rapidly evolve, Sarah shares how organizations can rethink traditional models and build smarter, patient-first campaigns.